KAITLYN COLLINS: Open Payments
NPI 1770104366 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 28 payments from 12 companies in 2025. Trend: 2023 $1,121 · 2024 $971 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $137 |
| Novo Nordisk Inc | 6 | $135 |
| Amgen Inc. | 5 | $86 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $55 |
| Amphastar Pharmaceuticals, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $21 |
| KYOWA KIRIN, INC. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Ascendis Pharma Endocrinology Inc | 1 | $19 |
Products named: Ozempic, TEPEZZA, JARDIANCE, MOUNJARO, ISTURISA, RECORLEV, Wegovy, MINIMED 780G.
Industry payments across MI — which companies pay providers there.
